Caryn Domenici, RPh

Trilipix has been approved by the FDA, the first and only fibrate indicated for use in combination with a statin for cholesterol management.

This single, longer-acting R-enantiomer of the racemic modafinil has been approved as a wakefulness-promoting drug.

This novel agent for HIV patients received accelerated FDA approval.

This drug is a novel single-entity tablet, combining a dihydropyridine calcium channel blocker and an angiotensin receptor blocker.

Ms. Domenici and Dr. Patel are both pharmacists at Brigham and Women's Hospital, Boston, Mass.

Ms. Domenici and Dr. Patel are both pharmacists at Brigham and Women's Hospital, Boston, Mass.

Ms. Domenici and Dr. Patel are both pharmacists at Brigham and Women's Hospital, Boston, Mass. Ms. Aiello is a sixth-year PharmD candidate from Massachusetts College of Pharmacy currently on clinical clerkship in the Investigational Drug Service at Brigham and Women's Hospital.